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doi:10.1016/j.tcmj.2012.02.001Costello syndrome (MIM number 218040) is a rare genetic
disorder caused by mutation in the v-Ha-ras Harvey rat sarcoma
viral oncogene homolog (HRAS) gene. Clinically, patients present
with distinctive facial features, cutaneous manifestations and skel-
etal abnormalities. This syndrome is also called facio-cutaneous-
skeletal syndrome.
Our patient was a 28-year-old woman, with a deep, hoarse
voice, who was referred from the dermatological department for
genetic diagnosis. She was a member of the indigenous Amis tribe.
There was no knowing family history of consanguinity or other
affected members. Her medical history revealed severely delayed
developmental milestones and severemental retardation. Since she
was 18 years old, the patient had no social activity and no self care
ability in daily life, because she easily became dyspneic. She
received a bilateral tympanoplasty at the age of 25 years because of
cholesteatomas. She had one episode of paroxysmal supraventric-
ular tachycardia at the age of 26, but a 24 hour Holter monitor
revealed no pathological ﬁndings.
Physically, the patient had a prominent forehead, a head
circumference of 54 cm (e1 SD), short stature (139 cm, e4.5 SD)
and an optimal body weight (43.7 kg, -1 SD). She had a coarse face,
thick lips, a large mouth, depressed nasal bridge, bulbous nose,
coarse voice, and curly, sparse hair. Low-set pinnae with large lobes
were also noted (Fig. 1). Cutaneous manifestations include sweaty,
oily, hyperpigmented skin, a loose skin texture, very deep palmar/
plantar creases, hyperkeratosis with underlying pinkish skin andFig. 1. Typical facial features of individuals with Costello syndrome with curly, sparse
hair, a long face, sweaty, oily, hyperpigmented skin, thick eyebrows and eyelids,
strabismus, a depressed nasal bridge, bulbous nose, large mouth with thick lips, and
low-set pinnae with large lobes (with father’s consent for publication).
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Fig. 2. Cutaneous manifestations of Costello syndrome. (A) and (B) Deep palmar creases and hyperkeratosis. (C) Deep nipple color with papillomas. (D) and (E) Deep plantar creases,
pigmented lesions on the ankle, and hyperkeratosis with underlying pinkish skin.
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papillomas (Fig. 2). Skeletal anomalies included hyperextensible
joints and thoracolumbar scoliosis shown on an image study. Bone
mineral densitometry showedmoderate osteoporosis (Z-Score:e3.7
SD, T score: e3.7).
She also had moderate mitral valve regurgitation, pulmonary
valve and tricuspid valve insufﬁciency, hypertrophic cardiomy-
opathy and severe hypertension (systolic/diastolic blood pres-
sure: 160w174/107w130 mmHg). Ophthalmologic examination
revealed amblyopia, premature cataracts, partial optic atrophy,
nystagmus and high myopia. Her hearing was normal. She also had
amelogenesis imperfecta and attrition, hypertrophic gingiva and
gingivitis, andheavycalculusdeposition. Shewasmalnourishedwith
generally lowplasma amino acid levels and a low level of insulin-like
growth factor 1 (68.9 ng/mL, normal¼ 100w 500 ng/mL). A skin
biopsy revealed dermatitis with elongation of the rete ridge, andFig. 3. Skin biopsy. Microscopically, there is chronic dermatitis with elongation of the
rete ridge accompanied by microabscess formation in the keratin layer and mild
chronic inﬂammatory cell inﬁltration in the upper dermis.multiple abscess formation in the keratin layer (Fig. 3). HRAS gene
sequencing analysis revealed a de novo G to A missense mutation
in nucleotide 34 (c.34 G/A), leading to an amino acid change from
serine to glycine (p.G12S) (Fig. 4). Since the HRAS protein is
responsible for regulation of cell growth and division, patients
with Costello syndrome are predisposed to both benign andFig. 4. HRAS gene analysis reveals de novo G to A transition in exon 2 (c.34 G/A),
leading to an amino acid change from glycine to serine (p.G12S). HRAS: v-Ha-ras
Harvey rat sarcoma viral oncogene homolog.
C.-Y. Weng et al. / Tzu Chi Medical Journal 25 (2013) 61e63 63malignant neoplasms. A panel of serum tumor markers revealed
mild elevation of the carcinoembryonic antigen level to10.1 ng/mL
(normal¼ 0e3 ng/mL). Abdominal and pelvis computed tomog-
raphy showed normal results.
Her treatment included dental care, and medications for
hypertension and cardiomyopathy. A low salt, low lipid diet, which
included adequate calories, was designed, along with a gradual
increase in daily physical activity. Treatment of osteoporosis
included different strategies, such as bracing for scoliosis, synthetic
polypeptide hormone injection, oral bisphosphonate, sun exposure
and supplementation with calcium and active vitamin D. Derma-
tological management included phototherapy, cutaneous applica-
tion of a keratolytic agent, lubricants, and anti-inﬂammatory
agents. Genetic counseling was offered to the patient and the
whole family. Social andmedical resources, and a home care project
to look after her, were provided. She is now 31 years old, and livesan outgoing and highly sociable life, which is characteristic of
patients with Costello syndrome after collaborative interprofes-
sional medical care.Further reading
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